ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

Temporal Trends of Arthropathies Related Mortality in the United States and Its Regional Variations from 1999-2018

Hafsa Akbar1, Waqar Mughal2, Hasan Mirza3, Ikwinder Kaur4, Harjot Jagdey5 and Mohsin Mughal6, 1Abington Jefferson Hospital, Abington, PA, 2University of Gujrat, Gujrat, Pakistan, 3Berkshire Medical Center, Pittsfield, MA, 4Monmouth Medical Center, an affiliate of Rutgers health system, Long Branch, NJ, 5BronxCare Hospital, Bronx, NY, 6Monmouth Medical Center, Long Branch, NJ

Meeting: ACR Convergence 2021

Keywords: Arthropathy, Mortality

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Epidemiology & Public Health Poster III: Other Rheumatic & Musculoskeletal Diseases (1022–1060)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Temporal trends of arthropathies-related mortality in the United States are not well studied. Arthropathies include Infectious arthropathies, Inflammatory poly-arthropathies, osteoarthritis, and other joint disorders. It is reasonable to speculate that with the advancement in the field of rheumatology, availability of new immune therapies, and persistent guideline-based high-quality treatment, arthropathies-related mortality rates would have trended down over the last two decades. We wanted to investigate the mortality rates and temporal trends of arthropathies related mortality in the United States using nationwide data.

Methods: In this retrospective study death certificate data were retrieved from the Center for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research (WONDER) database for 1999-2018. WONDER database is publicly available de-identified data collected by CDC that reports the underlying cause of death across the United States. Mortality, for arthropathies (M00-M25) as an underlying cause of death, was queried. This duration was further stratified into five-year periods from 1999-2018. Age-adjusted mortality rate (AAMR) per 100,000 population was calculated with 95% CI for the four U.S. census regions (CR1 Northeast, CR2 Midwest, CR3 South, and CR4 West).

Results: From 1999-2018 overall arthropathies-related age-adjusted mortality rate (AAMR) declined by 43.75%. Arthropathies-related AAMR for Northeast (CR-1) declined by 18.18 %, for Midwest (CR-2) declined by 42.10%, for South (CR-3) declined by 46.66%; for West (CR-4) declined by 37.5%. Regional and overall crude rates with 95% CI, are reported in Table-1; and Table 2. Temporal trends are illustrated in Figure-1.

Conclusion: Our study shows a downward trajectory of arthropathies-related mortality in all U.S census regions. Regional variations warrant further discovery. This data reinforces the continuation of high-quality care and evidence-based practices that may have played a role in declining AAMR for arthropathies-related mortality in the U.S. Major limitation of our study is the inherent weakness of the WONDER database and the inability to report AAMR for different MKS related disorders (SLE, rheumatoid arthritis).

Table_1 shows crude and age-adjusted mortality rate with 95% CI, from 1999_2018 for arthropathies as the underlying cause of death in four U.S census regions

Table_2 shows overall AAMR for arthropathies as the underlying cause of death in the U.S from 1999_2008

Figure_1 illustrates the age-adjusted mortality rate per 100,000 population due to arthropathies (M00-M25) in four U.S census regions from 1999_2018


Disclosures: H. Akbar, None; W. Mughal, None; H. Mirza, None; I. Kaur, None; H. Jagdey, None; M. Mughal, None.

To cite this abstract in AMA style:

Akbar H, Mughal W, Mirza H, Kaur I, Jagdey H, Mughal M. Temporal Trends of Arthropathies Related Mortality in the United States and Its Regional Variations from 1999-2018 [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/temporal-trends-of-arthropathies-related-mortality-in-the-united-states-and-its-regional-variations-from-1999-2018/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-trends-of-arthropathies-related-mortality-in-the-united-states-and-its-regional-variations-from-1999-2018/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology